BOSTON, Oct. 23 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, Ph.D., Corporate Vice President, PAREXEL Consulting, has received a Lifetime Achievement Award from the Good Clinical Practice Journal (GCPj). Dr. Grignolo was honored at the GCPj Awards ceremony, recognizing excellence in clinical research, which was held October 22, 2008 at the Banqueting House in London, England.
According to Helena Jensen, Publisher of the Good Clinical Practice Journal, "GCPj's Lifetime Achievement Award is presented to an exceptional individual with a distinguished career in the field of clinical development. We are pleased to honor Dr. Grignolo, who exemplifies dedication to advancing critical aspects of our industry, and whose achievements are especially notable for being consistently forward looking and visionary, from the championing of personalized medicine to his current role on the Executive Committee of the Clinical Trials Transformation Initiative."
"This honor from the GCPj readership and global clinical development community is for me not an end but rather a new beginning. This recognition is a challenge to inspire others to pursue our shared mission to prevent and cure disease, while continuing to improve the clinical trial enterprise and worldwide standards and practices to benefit patients. Together, through the important work that we do, we can promote innovation, help make personalized therapy a reality in our lifetime, meet urgent medical needs, insist on integrity and ethical behavior, and improve patient access to treatments," said Dr. Grignolo.
With more than 26 years of experience in regulator
|SOURCE PAREXEL International Corporation|
Copyright©2008 PR Newswire.
All rights reserved